TRIAL UPDATE
December 2024:
The trial’s results
Key findings of the WOMAN-2 trial and IPD meta-analysis study and reflections on the trial by our collaborators
NEWSLEttER
September 2023
Celebrating an incredible milestone: WOMAN-2 trial achieves target of 15,000 randomised women
TRIAL UPDATE
August 2023:
It’s the final countdown
Well done to WOMAN-2 sites for over 14,000 women randomised.
newsletter
June 2023
Severe anaemia linked to seven-fold increased risk of death or life-threatening bleeding after childbirth.
newsletter
April 2023
Lifesaving drug for severe bleeding after childbirth could be made accessible for all.
newsletter
March 2023
A call for global action on International Women’s Day to address the leading cause of maternal death worldwide.
Trial update
December 2022:
End of year update
Congratulations on the most successful year for the WOMAN-2 Trial.
Trial update
December 2021:
End of year update
Thank you for an amazing year – 6620 women randomised.
Trial update
December 2020:
End of year update
Hospitals have restarted the trial, after recruitment stopped due to COVID-19.